Grade 1–2 | Grade 3 | Grade 4 | |
---|---|---|---|
Acute (≤ 3 months post-treatment) toxicity incidence in N = 37 patients | |||
NONE | N = 11 (30%) | ||
Diarrhoea | N = 5 (14%) | 0 | 0 |
Nausea | N = 8 (22%) | 0 | 0 |
Vomiting | N = 2 (5%) | 0 | 0 |
Dyspepsia | N = 2 (5%) | 0 | 0 |
Anorexia | N = 2 (5%) | 0 | 0 |
Pain | N = 7 (19%) | N = 1 (3%) | 0 |
Fatigue | N = 11 (30%) | N = 1 (3%) | 0 |
Jaundice | N = 1 (3%) | 0 | 0 |
Obstructive Jaundice | 0 | N = 1 (3%) | 0 |
Late (> 3 months post-treatment) toxicity incidence in N = 32 | |||
NONE | N = 27 (84%) | ||
Pain | N = 1 (3%)* | 0 | 0 |
Nausea | N = 1 (3%)* | 0 | 0 |
Pancreatic Insufficiency | N = 1 (3%) | 0 | 0 |
GI Bleeding | 0 | 0 | N = 2 (6%) |
Duodenal Stricture | 0 | 0 | N = 2 (6%) |